« Back
Home /
Motexafin gadolinium

Motexafin gadolinium

Item no.	TMO-T33487-5mg
Manufacturer	TargetMol
CASRN	246252-06-2
Amount	5 mg
Quantity options	100 mg 25 mg 500 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	0,98
Smiles	CCC1=C2[N-]3[Gd+3]456([N](c7c([N]4=CC4=[N]5C(=CC3=C1CC)C(CCCO)=C4C)cc(c(c7)OCCOCCOCCOC)OCCOCCOCCOC)=CC1=[N]6C(=C2)C(CCCO)=C1C)([O-]C(=O)C)[O-]C(=O)C \|c:10,12,15,18,27,57,59,62,69,t:2,^1:4,6,9,12,54\|
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	PCI0120,Gd texaphyrin,PCI-0120,PCI 0120,Gd-Texgadolinium,API-GP 3
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Others
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	1148.42
Description	Motexafin gadolinium, also known as PCI 0120, is a synthetic metallotexaphyrin with radiosensitizing and chemosensitizing properties. Motexafin gadolinium accumulates in tumor cells preferentially due to their increased rates of metabolism, generating reactive oxygen species (ROS) intracellularly and lowering the tumor cell apoptotic threshold to ionizing radiation and chemotherapy.
Pathways	Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question